{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for estramustine root_references_citation in Reference Text / Citation (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 333C
(2014)
Source URL:
First approved in 2014
Source:
21 CFR 333C
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M020
(2024)
Source URL:
First approved in 2013
Source:
21 CFR 333D
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NDA215985
(2011)
Source URL:
First approved in 2011
Source:
NDA215985
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Secret Dig Hair Removal Foam by Yiwu Mijue electronic Commerce Co., LTD
(2024)
Source URL:
First approved in 2011
Source:
M020
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2011
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333E
(1997)
Source URL:
First approved in 1997
Source:
21 CFR 333E
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA065488
(1991)
Source URL:
First approved in 1989
Source:
21 CFR 343
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT04026438: Phase 4 Interventional Completed Complication, Postoperative
(2019)
Source URL:
First approved in 1983
Source:
NADA125961
Source URL:
Class:
MIXTURE
Class:
PROTEIN
